Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C.

Colmenero, Jordi

Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. [electronic resource] - American journal of physiology. Gastrointestinal and liver physiology Oct 2009 - G726-34 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1522-1547

10.1152/ajpgi.00162.2009 doi


Adaptor Proteins, Signal Transducing
Adaptor Proteins, Vesicular Transport--genetics
Administration, Oral
Angiotensin II Type 1 Receptor Blockers--administration & dosage
Biopsy, Needle
Collagen--genetics
Down-Regulation
Female
Gene Expression Regulation, Enzymologic--drug effects
Hepatitis C, Chronic--complications
Humans
Inflammation Mediators--metabolism
Liver--drug effects
Liver Cirrhosis--drug therapy
Losartan--administration & dosage
Male
Matrix Metalloproteinase 2--genetics
Middle Aged
NADPH Oxidases--genetics
Reverse Transcriptase Polymerase Chain Reaction
Severity of Illness Index
Spain
Time Factors
Treatment Outcome
Urokinase-Type Plasminogen Activator--genetics
rac1 GTP-Binding Protein--genetics